Guangzhou Wondfo Biotech Co Ltd (300482) — Strategic Asset Allocation Index
Guangzhou Wondfo Biotech Co Ltd (300482) has a Strategic Asset Allocation Index of 26.2% as of December 2022. Strategic assets (PP&E of CN¥1.19 Billion plus long-term investments of CN¥-) total CN¥1.19 Billion, measured against net assets of CN¥4.54 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check 300482 financial resilience to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Guangzhou Wondfo Biotech Co Ltd Strategic Asset Allocation Index (2011–2022)
This chart shows how Guangzhou Wondfo Biotech Co Ltd's Strategic Asset Allocation Index has evolved across 12 annual periods from 2011 to 2022. As of December 2022, the index stands at 26.2%, representing strategic assets of CN¥1.19 Billion against net assets of CN¥4.54 Billion CNY. See Guangzhou Wondfo Biotech Co Ltd (300482) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Guangzhou Wondfo Biotech Co Ltd (2011–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Guangzhou Wondfo Biotech Co Ltd from 2011 to 2022, covering 12 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see 300482 company net worth.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 26.2% | CN¥1.19 Billion | CN¥1.19 Billion | CN¥- | CN¥4.54 Billion | ▲ +0.4 pp |
| 2021 | 25.9% | CN¥906.09 Million | CN¥906.09 Million | CN¥- | CN¥3.50 Billion | ▲ +3.3 pp |
| 2020 | 22.6% | CN¥676.63 Million | CN¥676.63 Million | CN¥- | CN¥2.99 Billion | ▲ +2.0 pp |
| 2019 | 20.6% | CN¥505.86 Million | CN¥505.86 Million | CN¥- | CN¥2.46 Billion | ▼ -6.6 pp |
| 2018 | 27.2% | CN¥584.50 Million | CN¥396.68 Million | CN¥187.82 Million | CN¥2.15 Billion | ▼ -5.0 pp |
| 2017 | 32.1% | CN¥382.54 Million | CN¥254.12 Million | CN¥128.41 Million | CN¥1.19 Billion | ▲ +5.2 pp |
| 2016 | 26.9% | CN¥230.01 Million | CN¥223.77 Million | CN¥6.24 Million | CN¥854.75 Million | ▼ -2.4 pp |
| 2015 | 29.3% | CN¥205.08 Million | CN¥151.18 Million | CN¥53.90 Million | CN¥700.64 Million | ▼ -17.5 pp |
| 2014 | 46.7% | CN¥146.49 Million | CN¥146.49 Million | CN¥- | CN¥313.43 Million | ▼ -9.8 pp |
| 2013 | 56.5% | CN¥136.44 Million | CN¥136.44 Million | CN¥- | CN¥241.47 Million | ▼ -13.4 pp |
| 2012 | 69.9% | CN¥127.52 Million | CN¥127.52 Million | CN¥- | CN¥182.48 Million | ▼ -6.5 pp |
| 2011 | 76.4% | CN¥110.48 Million | CN¥110.48 Million | CN¥- | CN¥144.61 Million | — |